查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1978052

2026年全球生物技术领域人工智慧市场报告

AI In Biotechnology Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，生物技术领域的人工智慧（AI）市场发展迅速。预计该市场规模将从2025年的55.2亿美元成长到2026年的68.7亿美元，复合年增长率（CAGR）为24.4%。过去几年的成长主要归因于生物数据可用性的提高、生物资讯学的早期应用、药物研发成本的上升、对快速诊断方法的需求以及基因组研究的拓展等因素。

预计未来几年，生物技术领域的人工智慧市场将快速成长，到2030年将达到163.2亿美元，复合年增长率（CAGR）为24.1%。预测期内的成长要素包括机器学习演算法的进步、精准医疗的扩展、生命科学领域人工智慧投资的增加、对经济高效的药物研发的需求以及人工智慧与实验室自动化的融合。预测期内的关键趋势包括人工智慧驱动的药物发现、预测基因组学分析、自动化临床试验优化、人工智慧辅助诊断以及数据驱动的个人化医疗。

人工智慧（AI）的日益普及预计将推动生物技术领域人工智慧市场的成长。人工智慧是指利用机器（尤其是电脑系统）模拟人类认知功能，以执行学习、推理和问题解决等任务。人工智慧应用的普及主要得益于各行各业效率、准确性和决策能力的提升，尤其是在高精度复杂数据分析自动化方面。在生技领域，人工智慧将显着加速药物研发，简化研究流程，并增强预测建模能力，最终有助于改善医疗效果。例如，根据英国科学、技术和创新部 (DSIT) 于 2024 年 10 月发布的报告，人工智慧相关活动在 2023 年显着成长。具体而言，人工智慧相关企业的数量增加了 17%（新增 543 家公司），人工智慧相关收入成长了 34%（新增 36 亿英镑），就业人数增加了 29%（新增 14,500 人），增加价值 (GVA) 较 2022 年成长了近 57%（新增 211 亿英镑）。人工智慧应用的扩展正在推动人工智慧驱动的生物技术市场的成长。

生物技术领域的主要企业正优先开发先进技术，例如用于抗体发现的人工智慧平台，以巩固其市场地位。这些平台利用人工智慧高效识​​别和优化治疗性抗体，加速药物研发，同时降低成本并改善临床疗效。例如，2023年2月，总部位于以色列的创投工作室AION Labs发布了DenovAI，这是一个专门用于发现新型治疗性抗体的创新平台。这个尖端系统整合了机器学习和计算生物物理学，能够识别高亲和性抗体候选物，从而提高序列多样性、准确性并缩短研发週期。 DenovAI代表着生物技术领域的重大飞跃，它能够实现更快、更经济高效的药物发现，并提高各种疾病领域的临床成功率。

目录

第一章：执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球生物技术领域人工智慧市场：吸引力评分与分析
  • 成长潜力分析、竞争评估、策略适宜性评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 清单：主要原料、资源和供应商
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章：全球市场趋势与策略

  • 关键科技与未来趋势
    • 生物技术、基因组学和精准医疗
    • 人工智慧（AI）和自主人工智慧
    • 数位化、云端运算、巨量资料、网路安全
    • 工业4.0和智慧製造
    • 永续性、气候技术、循环经济
  • 主要趋势
    • 人工智慧驱动的药物发现
    • 预测基因组分析
    • 优化自动化临床试验
    • 人工智慧驱动的诊断技术
    • 数据驱动的个人化医疗

第五章 终端用户产业市场分析

  • 製药公司
  • 生技公司
  • 学术研究机构
  • 医疗保健提供者
  • CRO（受託研究机构）

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及 COVID-19 疫情对市场的影响。

第七章：全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球生物技术领域人工智慧市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 全球人工智慧市场规模、比较及成长率分析（生物技术领域）
  • 全球人工智慧市场在生物技术领域的表现：规模与成长，2020-2025年
  • 全球生物技术领域人工智慧市场预测：规模与成长，2025-2030年及2035年预测

第八章：全球市场总规模（TAM）

第九章 市场细分

  • 按组件
  • 软体、硬体和服务
  • 透过使用
  • 药物发现与开发、临床试验与优化、医学影像、诊断及其他应用领域
  • 最终用户
  • 製药公司、生物技术公司、学术研究机构、医疗保健提供者、受託研究机构(CRO) 和合约开发与生产组织 (CDMO) 以及其他最终用户
  • 按类型细分：软体
  • 人工智慧资料分析工具、机器学习演算法、生物资讯软体、药物发现平台、临床试验管理软体
  • 按类型细分：硬体
  • 高效能运算（HPC）系统、人工智慧整合成像设备、资料储存解决方案、实验室自动化设备、穿戴式健康监测设备。
  • 按类型细分：服务
  • 人工智慧实施和整合服务、咨询和培训服务、基于云端的人工智慧解决方案、维护和支援服务、客製化人工智慧模型开发。

第十章 市场与产业指标：依国家划分

第十一章 区域与国别分析

  • 全球生物技术领域人工智慧市场：按地区划分，实际数据和预测数据，2020-2025年、2025-2030年、2035年
  • 全球生物技术领域人工智慧市场：按国家划分，实际数据和预测数据，2020-2025年、2025-2030年、2035年

第十二章 亚太市场

第十三章：中国市场

第十四章：印度市场

第十五章：日本市场

第十六章：澳洲市场

第十七章：印尼市场

第十八章：韩国市场

第十九章 台湾市场

第二十章：东南亚市场

第21章 西欧市场

第22章英国市场

第23章：德国市场

第24章：法国市场

第25章：义大利市场

第26章：西班牙市场

第27章 东欧市场

第28章：俄罗斯市场

第29章 北美市场

第三十章：美国市场

第31章：加拿大市场

第32章：南美洲市场

第33章：巴西市场

第34章 中东市场

第35章：非洲市场

第三十六章 市场监理与投资环境

第37章：竞争格局与公司概况

  • 生物技术领域人工智慧市场：竞争格局及市场占有率（2024 年）
  • 生物技术领域人工智慧市场：公司估值矩阵
  • 生物技术领域人工智慧市场：公司概况
    • Google LLC
    • Pfizer Inc.
    • Johnson & Johnson Services Inc.
    • F. Hoffmann-La Roche Ltd.
    • International Business Machines Corporation（IBM）

第38章 其他大型企业和创新企业

  • Bayer AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca Plc, Abbott Laboratories, Novartis AG, Roivant Sciences Ltd., Gilead Sciences Inc., NVIDIA Corporation, Amgen Inc., Novo Nordisk A/S, Merck KGaA, Biogen Inc., CareDx Inc., Clario Inc.

第39章 全球市场竞争基准分析与仪錶板

第四十章 重大併购

第41章 具有高市场潜力的国家、细分市场与策略

  • 2030年生物技术领域人工智慧市场：提供新机会的国家
  • 2030年生物技术领域人工智慧市场：新兴机会细分市场
  • 2030年生物技术领域人工智慧市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第42章附录

简介目录
Product Code: IT3MABIO08_G26Q1

Artificial intelligence (AI) in biotechnology involves the application of machine learning and data-driven algorithms to interpret biological data and accelerate scientific research. It plays a vital role in areas such as drug discovery, genomics, diagnostics, and personalized medicine by recognizing patterns and forecasting outcomes. AI improves operational efficiency, reduces research costs, and provides deeper insights into complex biological systems, fueling innovation in healthcare and life sciences.

The primary components of AI in biotechnology include software, hardware, and services. Software in this context consists of sophisticated computational tools and algorithms that analyze biological data, simulate complex biological systems, and speed up processes such as drug development, genomic analysis, and precision medicine. It supports applications such as drug discovery and development, clinical trial optimization, medical imaging, diagnostics, and more, serving end users such as pharmaceutical and biotechnology companies, academic and research institutions, healthcare providers, contract research organizations (CROs), contract development and manufacturing organizations (CDMOs), and others.

Tariffs have impacted the AI in biotechnology market by increasing costs of high performance computing systems, laboratory automation equipment, and advanced imaging devices. Biotechnology firms deploying AI driven research platforms face higher capital expenditures. North America, Europe, and Asia Pacific are most affected due to reliance on global equipment suppliers. These tariffs can slow adoption for smaller research organizations. However, tariffs are encouraging local manufacturing of biotech instruments and computing infrastructure. This is strengthening regional life sciences ecosystems and long term innovation capacity.

The AI in biotechnology market research report is one of a series of new reports from The Business Research Company that provides AI in biotechnology market statistics, including AI in biotechnology industry global market size, regional shares, competitors with a AI in biotechnology market share, detailed AI in biotechnology market segments, market trends and opportunities, and any further data you may need to thrive in the AI in biotechnology industry. This AI in biotechnology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The AI in biotechnology market size has grown exponentially in recent years. It will grow from $5.52 billion in 2025 to $6.87 billion in 2026 at a compound annual growth rate (CAGR) of 24.4%. The growth in the historic period can be attributed to growth of biological data availability, early bioinformatics adoption, rising drug development costs, demand for faster diagnostics, expansion of genomics research.

The AI in biotechnology market size is expected to see exponential growth in the next few years. It will grow to $16.32 billion in 2030 at a compound annual growth rate (CAGR) of 24.1%. The growth in the forecast period can be attributed to advancements in machine learning algorithms, expansion of precision medicine, increasing AI investment in life sciences, demand for cost efficient drug development, integration of AI with laboratory automation. Major trends in the forecast period include AI driven drug discovery, predictive genomics analysis, automated clinical trial optimization, AI enabled diagnostics, data centric personalized medicine.

The growing adoption of artificial intelligence (AI) is anticipated to drive the expansion of the AI in biotechnology market. AI refers to the simulation of human cognitive functions by machines, particularly computer systems, to execute tasks such as learning, reasoning, and problem-solving. The rise in AI adoption is fueled by its ability to improve efficiency, precision, and decision-making across a wide range of industries, particularly through automating complex data analysis with high accuracy. In biotechnology, AI significantly accelerates drug discovery, streamlines research processes, and enhances predictive modeling, ultimately contributing to better healthcare outcomes. For example, in October 2024, the UK's Department for Science, Innovation & Technology (DSIT) reported a notable increase in AI activity in 2023, including a 17% rise in the number of AI companies (+543), a 34% boost in AI-generated revenue (+£3.6 billion), a 29% growth in employment (+14,500), and a nearly 57% increase in gross value added (GVA) (+£2.1 billion) compared to 2022. As a result, the expanding adoption of AI is propelling growth in the AI-driven biotechnology market.

Leading companies in the AI in biotechnology sector are prioritizing the development of advanced technologies, such as AI-powered platforms for antibody discovery, to strengthen their market position. These platforms leverage AI to efficiently identify and optimize therapeutic antibodies, accelerating drug development while reducing costs and improving clinical outcomes. For instance, in February 2023, AION Labs, a venture studio based in Israel, introduced DenovAI-an innovative platform dedicated to the de novo discovery of therapeutic antibodies. This state-of-the-art system integrates machine learning with computational biophysics to identify high-affinity antibody candidates, offering greater sequence diversity, enhanced precision, and shorter development cycles. DenovAI represents a significant leap in biotechnology, facilitating faster, more affordable drug discovery and increasing the likelihood of clinical success across various disease areas.

In February 2025, Incyte Corporation, a U.S.-based biopharmaceutical firm, entered into a strategic partnership with Genesis Therapeutics Inc. to harness the potential of AI in enhancing drug discovery efficiency. The partnership combines Incyte's deep expertise in drug development with Genesis Therapeutics' proprietary AI platform to accelerate the discovery and refinement of innovative small molecule therapies for targeted oncology treatments. Genesis Therapeutics Inc. is a U.S.-based biotechnology company that specializes in AI-powered drug discovery, aiming to revolutionize therapeutic development through advanced technological applications.

Major companies operating in the AI in biotechnology market are Google LLC, Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., International Business Machines Corporation (IBM), Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca Plc, Abbott Laboratories, Novartis AG, Roivant Sciences Ltd., Gilead Sciences Inc., NVIDIA Corporation, Amgen Inc., Novo Nordisk A/S, Merck KGaA, Biogen Inc., CareDx Inc., Clario Inc., BenevolentAI Limited, Recursion Pharmaceuticals Inc., Insilico Medicine Inc., Genesis Therapeutics Inc.

North America was the largest region in the AI in biotechnology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the AI in biotechnology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the AI in biotechnology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The AI in biotechnology market consists of revenues earned by entities providing services such as genomics analysis, precision medicine development, biomanufacturing optimization, and AI-driven diagnostics. The market value includes the value of related goods sold by the service provider or included within the service offering. The AI in biotechnology market also includes sales of bioinformatics tools, automation systems, and AI-integrated laboratory equipment. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

AI In Biotechnology Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses AI in biotechnology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for AI in biotechnology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The AI in biotechnology market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Component: Software; Hardware; Services
  • 2) By Application: Drug Discovery And Development; Clinical Trials And Optimization; Medical Imaging; Diagnostics; Other Applications
  • 3) By End User: Pharmaceutical Companies; Biotechnology Companies; Academic And Research Institutes; Healthcare Providers; Contract Research Organization (CRO) And Contract Development And Manufacturing Organization (CDMO); Other End Users
  • Subsegments:
  • 1) By Software: AI-Powered Data Analytics Tools; Machine Learning Algorithms; Bioinformatics Software; Drug Discovery Platforms; Clinical Trial Management Software
  • 2) By Hardware: High-Performance Computing (HPC) Systems; AI-Integrated Imaging Devices; Data Storage Solutions; Laboratory Automation Equipment; Wearable Health Monitoring Devices
  • 3) By Services: AI Implementation And Integration Services; Consulting And Training Services; Cloud-Based AI Solutions; Maintenance And Support Services; Custom AI Model Development
  • Companies Mentioned: Google LLC; Pfizer Inc.; Johnson & Johnson Services Inc.; F. Hoffmann-La Roche Ltd.; International Business Machines Corporation (IBM); Bayer AG; Sanofi S.A.; Bristol-Myers Squibb Company; AstraZeneca Plc; Abbott Laboratories; Novartis AG; Roivant Sciences Ltd.; Gilead Sciences Inc.; NVIDIA Corporation; Amgen Inc.; Novo Nordisk A/S; Merck KGaA; Biogen Inc.; CareDx Inc.; Clario Inc.; BenevolentAI Limited; Recursion Pharmaceuticals Inc.; Insilico Medicine Inc.; Genesis Therapeutics Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. AI In Biotechnology Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global AI In Biotechnology Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. AI In Biotechnology Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global AI In Biotechnology Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Artificial Intelligence & Autonomous Intelligence
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Industry 4.0 & Intelligent Manufacturing
    • 4.1.5 Sustainability, Climate Tech & Circular Economy
  • 4.2. Major Trends
    • 4.2.1 AI Driven Drug Discovery
    • 4.2.2 Predictive Genomics Analysis
    • 4.2.3 Automated Clinical Trial Optimization
    • 4.2.4 AI Enabled Diagnostics
    • 4.2.5 Data Centric Personalized Medicine

5. AI In Biotechnology Market Analysis Of End Use Industries

  • 5.1 Pharmaceutical Companies
  • 5.2 Biotechnology Companies
  • 5.3 Academic And Research Institutes
  • 5.4 Healthcare Providers
  • 5.5 Contract Research Organizations

6. AI In Biotechnology Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global AI In Biotechnology Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global AI In Biotechnology PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global AI In Biotechnology Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global AI In Biotechnology Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global AI In Biotechnology Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global AI In Biotechnology Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. AI In Biotechnology Market Segmentation

  • 9.1. Global AI In Biotechnology Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Software, Hardware, Services
  • 9.2. Global AI In Biotechnology Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Drug Discovery And Development, Clinical Trials And Optimization, Medical Imaging, Diagnostics, Other Applications
  • 9.3. Global AI In Biotechnology Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Pharmaceutical Companies, Biotechnology Companies, Academic And Research Institutes, Healthcare Providers, Contract Research Organization (CRO) And Contract Development And Manufacturing Organization (CDMO), Other End Users
  • 9.4. Global AI In Biotechnology Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • AI-Powered Data Analytics Tools, Machine Learning Algorithms, Bioinformatics Software, Drug Discovery Platforms, Clinical Trial Management Software
  • 9.5. Global AI In Biotechnology Market, Sub-Segmentation Of Hardware, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • High-Performance Computing (HPC) Systems, AI-Integrated Imaging Devices, Data Storage Solutions, Laboratory Automation Equipment, Wearable Health Monitoring Devices
  • 9.6. Global AI In Biotechnology Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • AI Implementation And Integration Services, Consulting And Training Services, Cloud-Based AI Solutions, Maintenance And Support Services, Custom AI Model Development

10. AI In Biotechnology Market, Industry Metrics By Country

  • 10.1. Global AI In Biotechnology Market, Average Selling Price By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $
  • 10.2. Global AI In Biotechnology Market, Average Spending Per Capita (Employed) By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $

11. AI In Biotechnology Market Regional And Country Analysis

  • 11.1. Global AI In Biotechnology Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 11.2. Global AI In Biotechnology Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. Asia-Pacific AI In Biotechnology Market

  • 12.1. Asia-Pacific AI In Biotechnology Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. Asia-Pacific AI In Biotechnology Market, Segmentation By Component, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. China AI In Biotechnology Market

  • 13.1. China AI In Biotechnology Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 13.2. China AI In Biotechnology Market, Segmentation By Component, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. India AI In Biotechnology Market

  • 14.1. India AI In Biotechnology Market, Segmentation By Component, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Japan AI In Biotechnology Market

  • 15.1. Japan AI In Biotechnology Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 15.2. Japan AI In Biotechnology Market, Segmentation By Component, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Australia AI In Biotechnology Market

  • 16.1. Australia AI In Biotechnology Market, Segmentation By Component, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. Indonesia AI In Biotechnology Market

  • 17.1. Indonesia AI In Biotechnology Market, Segmentation By Component, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. South Korea AI In Biotechnology Market

  • 18.1. South Korea AI In Biotechnology Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. South Korea AI In Biotechnology Market, Segmentation By Component, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. Taiwan AI In Biotechnology Market

  • 19.1. Taiwan AI In Biotechnology Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. Taiwan AI In Biotechnology Market, Segmentation By Component, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. South East Asia AI In Biotechnology Market

  • 20.1. South East Asia AI In Biotechnology Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. South East Asia AI In Biotechnology Market, Segmentation By Component, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. Western Europe AI In Biotechnology Market

  • 21.1. Western Europe AI In Biotechnology Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 21.2. Western Europe AI In Biotechnology Market, Segmentation By Component, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. UK AI In Biotechnology Market

  • 22.1. UK AI In Biotechnology Market, Segmentation By Component, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. Germany AI In Biotechnology Market

  • 23.1. Germany AI In Biotechnology Market, Segmentation By Component, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. France AI In Biotechnology Market

  • 24.1. France AI In Biotechnology Market, Segmentation By Component, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Italy AI In Biotechnology Market

  • 25.1. Italy AI In Biotechnology Market, Segmentation By Component, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Spain AI In Biotechnology Market

  • 26.1. Spain AI In Biotechnology Market, Segmentation By Component, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Eastern Europe AI In Biotechnology Market

  • 27.1. Eastern Europe AI In Biotechnology Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 27.2. Eastern Europe AI In Biotechnology Market, Segmentation By Component, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. Russia AI In Biotechnology Market

  • 28.1. Russia AI In Biotechnology Market, Segmentation By Component, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. North America AI In Biotechnology Market

  • 29.1. North America AI In Biotechnology Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. North America AI In Biotechnology Market, Segmentation By Component, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. USA AI In Biotechnology Market

  • 30.1. USA AI In Biotechnology Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. USA AI In Biotechnology Market, Segmentation By Component, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. Canada AI In Biotechnology Market

  • 31.1. Canada AI In Biotechnology Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. Canada AI In Biotechnology Market, Segmentation By Component, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. South America AI In Biotechnology Market

  • 32.1. South America AI In Biotechnology Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 32.2. South America AI In Biotechnology Market, Segmentation By Component, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Brazil AI In Biotechnology Market

  • 33.1. Brazil AI In Biotechnology Market, Segmentation By Component, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Middle East AI In Biotechnology Market

  • 34.1. Middle East AI In Biotechnology Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Middle East AI In Biotechnology Market, Segmentation By Component, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Africa AI In Biotechnology Market

  • 35.1. Africa AI In Biotechnology Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 35.2. Africa AI In Biotechnology Market, Segmentation By Component, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

36. AI In Biotechnology Market Regulatory and Investment Landscape

37. AI In Biotechnology Market Competitive Landscape And Company Profiles

  • 37.1. AI In Biotechnology Market Competitive Landscape And Market Share 2024
    • 37.1.1. Top 10 Companies (Ranked by revenue/share)
  • 37.2. AI In Biotechnology Market - Company Scoring Matrix
    • 37.2.1. Market Revenues
    • 37.2.2. Product Innovation Score
    • 37.2.3. Brand Recognition
  • 37.3. AI In Biotechnology Market Company Profiles
    • 37.3.1. Google LLC Overview, Products and Services, Strategy and Financial Analysis
    • 37.3.2. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 37.3.3. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 37.3.4. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 37.3.5. International Business Machines Corporation (IBM) Overview, Products and Services, Strategy and Financial Analysis

38. AI In Biotechnology Market Other Major And Innovative Companies

  • Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca Plc, Abbott Laboratories, Novartis AG, Roivant Sciences Ltd., Gilead Sciences Inc., NVIDIA Corporation, Amgen Inc., Novo Nordisk A/S, Merck KGaA, Biogen Inc., CareDx Inc., Clario Inc.

39. Global AI In Biotechnology Market Competitive Benchmarking And Dashboard

40. Key Mergers And Acquisitions In The AI In Biotechnology Market

41. AI In Biotechnology Market High Potential Countries, Segments and Strategies

  • 41.1. AI In Biotechnology Market In 2030 - Countries Offering Most New Opportunities
  • 41.2. AI In Biotechnology Market In 2030 - Segments Offering Most New Opportunities
  • 41.3. AI In Biotechnology Market In 2030 - Growth Strategies
    • 41.3.1. Market Trend Based Strategies
    • 41.3.2. Competitor Strategies

42. Appendix

  • 42.1. Abbreviations
  • 42.2. Currencies
  • 42.3. Historic And Forecast Inflation Rates
  • 42.4. Research Inquiries
  • 42.5. The Business Research Company
  • 42.6. Copyright And Disclaimer